Acquisition Announced Sponsor buyer

Max Wygod acquisition of Forian

US$68m equity value

Announced 3 Apr 2026 · NASDAQ: FORA · US$2.17 cash per share

Advisers

Forian

Target

Financial adviser
Fairness opinion

Bravo Merger Sub

Acquirer

Legal adviser
A&O Shearman (as Allen Overy Shearman Sterling US LLP)
Information agent for the Offer
Broadridge Corporate Issuer Solutions
Target
Forian
Acquirer
Bravo Merger Sub (affiliate of Max Wygod-led consortium)
Sponsor
Max Wygod
Target based in
United States
Buyer based in
United States (unverified)
Sector
Healthcare Software
Tags
Healthcare Software, Data & Analytics

In the league tables

Similar deals

All healthcare software deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.